Dapagliflozin vs Montelukast

Dapagliflozin vs Montelukast: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Montelukast.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Montelukast — C35H36ClNO3S.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Montelukast — 586.1800 g/mol.

Type: Dapagliflozin — Small molecule; Montelukast — Small molecule.